Hemostemix Inc. (HEM.V)

CAD 0.1

(5.56%)

Revenue Summary of Hemostemix Inc.

  • Hemostemix Inc.'s latest annual revenue in 2023 was - CAD , down 0.0% from previous year.
  • Hemostemix Inc.'s latest quarterly revenue in 2024 Q2 was - CAD , down 0.0% from previous quarter.
  • Hemostemix Inc. reported a annual revenue of - CAD in annual revenue 2022, down 0.0% from previous year.
  • Hemostemix Inc. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Hemostemix Inc. reported a quarterly revenue of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Hemostemix Inc. reported a quarterly revenue of - CAD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Hemostemix Inc. (2023 - 2013)

Created with Highcharts 11.1.0YearsRevenue201320142015201620172018201920202021202220230 CAD

Historical Annual Revenue of Hemostemix Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%

Peer Revenue Comparison of Hemostemix Inc.

Name Revenue Revenue Difference
Arch Biopartners Inc. 1.98 Million CAD 100.0%
Covalon Technologies Ltd. 26.59 Million CAD 100.0%
Universal Ibogaine Inc. 1.07 Million CAD 100.0%
Kane Biotech Inc. 148.98 Thousand CAD 100.0%
MedMira Inc. 432.52 Thousand CAD 100.0%
Marvel Biosciences Corp. - CAD NaN%
NervGen Pharma Corp. - CAD NaN%
XORTX Therapeutics Inc. - CAD NaN%